TLDR
- ABM revenue rises 3.9% YoY, slightly above $2.19B analyst estimate.
- EPS misses at $0.83 vs. $0.87 forecast, driving stock down 1.28%.
- Peer performance mixed: Tetra Tech gains, Pitney Bowes rebounds.
- Analysts maintain $54.67 avg price target despite near-term challenges.
- Revenue stable but margin pressures create mixed market sentiment.
ABM Industries Incorporated (ABM) shares fell to $43.28, down 1.28% after releasing Q1 results. The company reported revenue of $2.2 billion, slightly above analysts’ $2.19 billion estimate. However, EPS came in at $0.83, missing the forecast of $0.87.
ABM Industries Incorporated, ABM
Revenue grew 3.9% year over year, improving from last year’s 2.2% increase in the same quarter. Analysts had maintained steady estimates in recent weeks, reflecting expectations for stable performance. ABM has historically met or slightly exceeded Wall Street’s revenue predictions.
Despite the top-line beat, the stock dropped as profitability disappointed. Full-year EPS guidance remains aligned with analyst expectations. Market reaction shows pressure on shares despite consistent revenue growth.
Q1 Performance and Peer Comparisons
ABM’s revenue growth contrasts with its peers in industrial and environmental services. Tetra Tech saw a 13.4% decline in revenue but beat estimates, while Pitney Bowes declined 7.5% and missed forecasts. Tetra Tech shares gained 3%, and Pitney Bowes rose 8.6% after reporting results.
The industrial services sector shows mixed performance amid economic uncertainty and potential regulatory changes. Overall, the segment has underperformed, with shares down 4.3% on average over the past month. ABM’s stock fell 6.2% during the same period, indicating above-average weakness.
Analysts set an average price target of $54.67 for ABM, significantly higher than the current $43.28. This gap suggests expectations for long-term recovery, though near-term results remain a challenge. ABM continues to face margin pressure while maintaining steady revenue growth.
Earnings Revisions and Financial Health
ABM experienced four positive EPS revisions and three negative revisions in the last 90 days. These mixed revisions reflect uncertainty in profit margins and operational efficiency. The company’s financial health score is classified as “fair performance,” showing moderate stability.
Q1 revenue slightly exceeded consensus, but the EPS shortfall highlights cost pressures and slower profit growth. Analysts expect the company to maintain steady revenue momentum for the remainder of the year. Share price performance reflects a combination of moderate growth and missed earnings expectations.
ABM continues to operate in a competitive industrial services market while adapting to economic fluctuations. Revenue stability contrasts with declining profit margins, creating mixed market sentiment. The stock remains below analyst targets despite a history of meeting revenue expectations.
Considering a new stock? You may want to see what’s on our watchlist first.
Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights.Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
